Our MDL-207 approach to Dravet Syndrome was featured in BioCentury.

Modalis Reports 2024 Financial Results and Operational Highlights

Modalis Therapeutics Reports Operational Highlights and Third Quarter 2024 Financial Results

Modalis Therapeutics and MDL-101 were featured on LAMA2 Europe’s website

Modalis Therapeutics and MDL-101 were featured on Cure CMD and LAMA2 Europe’s website (Updated)